293 related articles for article (PubMed ID: 21295623)
1. Identification of blood microRNAs associated to Parkinsonĭs disease.
Margis R; Margis R; Rieder CR
J Biotechnol; 2011 Mar; 152(3):96-101. PubMed ID: 21295623
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.
Miñones-Moyano E; Porta S; Escaramís G; Rabionet R; Iraola S; Kagerbauer B; Espinosa-Parrilla Y; Ferrer I; Estivill X; Martí E
Hum Mol Genet; 2011 Aug; 20(15):3067-78. PubMed ID: 21558425
[TBL] [Abstract][Full Text] [Related]
3. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
[TBL] [Abstract][Full Text] [Related]
4. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
[TBL] [Abstract][Full Text] [Related]
5. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.
Alieva AKh; Filatova EV; Karabanov AV; Illarioshkin SN; Limborska SA; Shadrina MI; Slominsky PA
Parkinsonism Relat Disord; 2015 Jan; 21(1):72-4. PubMed ID: 25465742
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-221 serves as a biomarker for Parkinson's disease.
Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.
Zhao N; Jin L; Fei G; Zheng Z; Zhong C
Parkinsonism Relat Disord; 2014 Nov; 20(11):1177-80. PubMed ID: 25218846
[TBL] [Abstract][Full Text] [Related]
8. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
[TBL] [Abstract][Full Text] [Related]
12. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease.
Bai X; Tang Y; Yu M; Wu L; Liu F; Ni J; Wang Z; Wang J; Fei J; Wang W; Huang F; Wang J
Sci Rep; 2017 Jul; 7(1):5411. PubMed ID: 28710399
[TBL] [Abstract][Full Text] [Related]
17. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
[TBL] [Abstract][Full Text] [Related]
18. Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum.
Ruf WP; Freischmidt A; Grozdanov V; Roth V; Brockmann SJ; Mollenhauer B; Martin D; Haslinger B; Fundel-Clemens K; Otto M; Arnim CV; Holzmann K; Ludolph AC; Weishaupt JH; Danzer KM
Cells; 2021 Apr; 10(4):. PubMed ID: 33918274
[TBL] [Abstract][Full Text] [Related]
19. A miRNA signature of prion induced neurodegeneration.
Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
[TBL] [Abstract][Full Text] [Related]
20. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans.
Li T; Cao H; Zhuang J; Wan J; Guan M; Yu B; Li X; Zhang W
Clin Chim Acta; 2011 Jan; 412(1-2):66-70. PubMed ID: 20888330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
